Document Detail

Polyarginines are potent furin inhibitors.
MedLine Citation:
PMID:  10958789     Owner:  NLM     Status:  MEDLINE    
The ubiquitous serine endoprotease furin has been implicated in the activation of bacterial toxins and viral glycoproteins as well as in the metastatic progression of certain tumors. Although high molecular mass bioengineered serpin inhibitors have been well characterized, no small nontoxic nanomolar inhibitors have been reported to date. Here we describe the identification of such inhibitors using positional scanning amidated and acetylated synthetic l- and d-hexapeptide combinatorial libraries. The results indicated that l-Arg or l-Lys in all positions generated the most potent inhibitors. However, further investigation revealed that the peptide terminating groups hindered inhibition. Consequently, a series of non-amidated and acetylated polyarginines was synthesized. The most potent inhibitor identified, nona-l-arginine, had a K(i) for furin of 40 nm. The K(i) values for the related convertases PACE4 and prohormone convertase-1 (PC1) were 110 nm and 2.5 microm, respectively. Although nona-l-arginine was cleaved by furin, the major products after a 6-h incubation at 37 degrees C were hexa- and hepta-l-arginines, both of which retained the great majority of their potency and specificity against furin. Hexa-d-arginine was as potent and specific a furin inhibitor as hexa-l-arginine (K(i) values of hexa-d-arginine: 106 nm, 580 nm, and 13.2 microm for furin, PACE4, and PC1, respectively). PC2 was not inhibited by any polyarginine tested; indeed, PC2 showed an increase in activity of up to 140% of the control in the presence of l-polyarginines. Data are also presented that show extended subsite recognition by furin and PC2. Whereas N-terminal acetylation was found to reduce the inhibitory potency of the l-hexapeptide LLRVKR against furin 8-fold, C-terminal amidation reduced the potency < 2-fold. Conversely, N-terminal acetylation increased the potency against PC2 nearly 3-fold, whereas C-terminal amidation of the same peptide increased the potency by a factor of 1.6. Our data indicate that non-acetylated, poly-d-arginine-derived molecules may represent excellent lead compounds for the development of therapeutically useful furin inhibitors.
A Cameron; J Appel; R A Houghten; I Lindberg
Related Documents :
19754199 - Identification of n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imid...
12057649 - Design, synthesis and biological activity of ym-60828 derivatives: potent and orally-bi...
22243519 - Mitochondrial atp synthase catalytic mechanism: a novel visual comparative structural a...
15911259 - Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanas...
17189639 - Production of authentic sars-cov m(pro) with enhanced activity: application as a novel ...
19428249 - Characterization of lassa virus cell entry inhibitors: determination of the active enan...
12364339 - Parkin accumulation in aggresomes due to proteasome impairment.
8117659 - Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical sele...
15705499 - Intra-subunit residue interactions from the protein surface to the active site of gluta...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of biological chemistry     Volume:  275     ISSN:  0021-9258     ISO Abbreviation:  J. Biol. Chem.     Publication Date:  2000 Nov 
Date Detail:
Created Date:  2001-01-08     Completed Date:  2001-01-08     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985121R     Medline TA:  J Biol Chem     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  36741-9     Citation Subset:  IM    
Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Peptide Library
Peptides / pharmacology*
Protein Conformation
Subtilisins / antagonists & inhibitors*
Grant Support
Reg. No./Substance:
0/Peptide Library; 0/Peptides; 25212-18-4/polyarginine; EC 3.4.21.-/Subtilisins; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by...
Next Document:  Functional heterogeneity in the zinc fingers of metalloregulatory protein metal response element-bin...